Bryan McColgan is currently an Associate Director of Clinical Research at Gilead Sciences, Inc. focusing on drug development for nonalcoholic fatty liver disease (NAFLD).  He completed his endocrinology fellowship at Stanford University.  A former United States Fulbright Fellow in Zimbabwe, he has also interned for the World Health Organization in Geneva and the medical unit of the CBS Evening News in New York.